Language Selector

    Upcoming IMI 2 Call 9

    Published on 13 April 2016
    Author: Marlen Damjanovic, National Contact Point Health, Demographic Change & Wellbeing

    The topics for the upcoming IMI 2 Call 9 are published.

    The following topics are under consideration for inclusion in IMI 2 - Call 9, which will be launched shortly:

    • Addressing the clinical burden of Clostridium difficile infection (CDI): evaluation of the burden, current practices and set up of a European research platform (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
    • Development of immune tolerance therapies for the treatment of rheumatic diseases
    • Data quality in preclinical research and development
    • Next generation of electronic translational safety – NEXGETS
    • Identification and validation of non-invasive markers across the spectrum of nonalcoholic fatty liver disease (NAFLD)
    • Joint influenza vaccine effectiveness surveillance

    All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be communicated after approval by the IMI Governing Board

    More Information